Pancreatic Cancer Research

ResearcherUniversity of AucklandActive in the last 2 years

Yan Li

Matched on ORCID iD 0000-0002-2781-2119; OpenAlex author ID A5100689299. Sources: OpenAlex.

Their work

Papers
6 (first author 3, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
12
Papers, trials and grants by year

2011: 1 paper · 2012: none · 2013: none · 2014: none · 2015: none · 2016: none · 2017: 2 papers · 2018: none · 2019: none · 2020: none · 2021: 1 paper · 2022: none · 2023: none · 2024: 2 papers

Papers 6

  1. Improved Antitumor Efficiency of N4 -Tetradecyloxycarbonyl Gemcitabine-Loaded Liposomes for Pancreatic Cancer Chemotherapy. Co-author DOI 10.2147/ijn.s485861↗
  2. Multidrug resistance protein 5 affects cell proliferation, migration and gemcitabine sensitivity in pancreatic cancer MIA Paca‑2 and PANC‑1 cells. Last author DOI 10.3892/or.2023.8666↗
  3. Co-Delivery Using pH-Sensitive Liposomes to Pancreatic Cancer Cells: the Effects of Curcumin on Cellular Concentration and Pharmacokinetics of Gemcitabine. First author DOI 10.1007/s11095-021-03072-2↗
  4. Curcumin and its cyclohexanone analogue inhibited human Equilibrative nucleoside transporter 1 (ENT1) in pancreatic cancer cells. First author DOI 10.1016/j.ejphar.2017.03.055↗
  5. miR-509-5p inhibits cellular proliferation and migration via targeting MDM2 in pancreatic cancer cells. First author DOI 10.2147/ott.s130378↗
  6. Modulatory effects of curcumin on multi-drug resistance-associated protein 5 in pancreatic cancer cells. Co-author DOI 10.1007/s00280-010-1515-6↗

Closest collaborators

The 12 strongest of 12 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Zimei Wu · 2 shared papers, 2021–2024 · strength 0.41
  2. James William Paxton · 3 shared papers, 2011–2021 · strength 0.31
  3. Xuewei Yang · 1 shared paper, 2024 · strength 0.22
  4. Ji He · 1 shared paper, 2024 · strength 0.22
  5. Mingliang Liu · 1 shared paper, 2024 · strength 0.21
  6. Guimin Xia · 1 shared paper, 2024 · strength 0.21
  7. Xiaowei Wang · 1 shared paper, 2024 · strength 0.21
  8. Dan Wang · 1 shared paper, 2024 · strength 0.21
  9. Hongtao Xu · 1 shared paper, 2021 · strength 0.19
  10. Jezrael L. Revalde · 2 shared papers, 2011–2017 · strength 0.11
  11. Xin Li · 1 shared paper, 2017 · strength 0.09
  12. Fei Chen · 1 shared paper, 2017 · strength 0.09

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.